Insight into diagnosis of pleural tuberculosis with special focus on nucleic acid amplification tests.
ALISA
Immuno-PCR
Mycobacterium tuberculosis
NAATs
biomarker
circulating cfDNA
diagnosis
histopathology
imaging
pleural TB
Journal
Expert review of respiratory medicine
ISSN: 1747-6356
Titre abrégé: Expert Rev Respir Med
Pays: England
ID NLM: 101278196
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
pubmed:
22
6
2022
medline:
30
9
2022
entrez:
21
6
2022
Statut:
ppublish
Résumé
Pleural tuberculosis (TB) is the archetype of extrapulmonary TB (EPTB), which mainly affects the pleural space and leads to exudative pleural effusion. Diagnosis of pleural TB is a difficult task predominantly due to atypical clinical presentations and sparse bacillary load in clinical specimens. We reviewed the current literature on the globally existing conventional/latest modalities for diagnosing pleural TB. Bacteriological examination (smear/culture), tuberculin skin testing/interferon-γ release assays, biochemical testing, imaging and histopathological/cytological examination are the main modalities. Moreover, nucleic acid amplification tests (NAATs), Routine tests are not adequate for effective pleural TB diagnosis. The latest molecular/immunological tests as discussed above, and the other tools,
Identifiants
pubmed: 35728039
doi: 10.1080/17476348.2022.2093189
doi:
Substances chimiques
Cell-Free Nucleic Acids
0
Tuberculin
0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM